Time-Restricted Feeding for Cardiovascular Disease Risk Factors
Trial Summary
What is the purpose of this trial?
This trial is testing whether eating only during certain hours of the day (time-restricted eating) can help people with prediabetes control their blood sugar, lose weight, and improve heart health. Participants will follow different eating schedules for a few months to see which is most effective. Time-restricted eating (TRE) is an emerging dietary intervention for weight loss and metabolic health, with various studies investigating its effects on body weight, fat oxidation, and heart health.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but you cannot participate if you are on diabetes medication or any medication that affects blood sugar or blood pressure rhythms.
What data supports the effectiveness of this treatment for cardiovascular disease risk factors?
Is time-restricted eating safe for humans?
How is time-restricted feeding different from other treatments for cardiovascular disease risk factors?
Time-restricted feeding (TRF) is unique because it involves eating only during a specific time window each day, which may help improve cardiovascular health by aligning eating patterns with the body's natural circadian rhythms. Unlike traditional treatments that might focus on medication or continuous calorie restriction, TRF emphasizes the timing of food intake, potentially offering a simpler and more natural approach to managing cardiovascular risk factors.3491011
Research Team
Courtney Peterson, Ph.D.
Principal Investigator
University of Alabama at Birmingham
Eligibility Criteria
This trial is for adults aged 30-65 with a BMI of 27-43 who regularly wake up between 5-8 am and are prediabetic. It's not suitable for those with psychiatric conditions, significant diseases, recent weight fluctuations, or on certain medications affecting glucose or blood pressure.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants are assigned to one of three time-restricted eating schedules for 8 weeks: Early TRE, Mid-day TRE, or Control Schedule. All food is provided and matched between groups.
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Control Schedule
- Early Time-Restricted Feeding
- Mid-day Time-Restricted Feeding
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Alabama at Birmingham
Lead Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator